Abstract
Objectives
Few studies compare gastroesophageal reflux (GER) parameters of cystic fibrosis (CF) children and symptomatic non-CF children. We aimed to compare the impedance-pH (IMP-pH) parameters for these two groups and to test the hypothesis that prolonged acid exposure in CF patients is due to delayed chemical clearance (CC).
Methods
IMP-pH tracings from 16 CF children (median 8.2 years) and 16 symptomatic non-CF children (median 8.3 years) were analyzed. Software was used to generate IMP-pH reports and parameter data were extracted. IMP-pH was used to calculate the mean CC for each patient.
Results
pH studies showed no difference in acid GER (AGER) frequency (p = 0.587); however, mean AGER duration, duration of longest AGER, AGER index, and DeMeester scores were all significantly higher for CF patients. IMP showed no difference in GER frequency [neither acidic (p = 0.918) nor non-acidic (p = 0.277)], but total bolus clearance was more efficient in CF patients (p = 0.049). A larger percentage of total GER reached the proximal esophagus in non-CF children (p = 0.039). Analyses of two-phase AGER episodes showed that these events were more acidic (p = 0.003) and the CC phase was significantly prolonged in the CF cohort (p = 0.001).
Conclusions
Compared to symptomatic non-CF children, CF children do not have more frequent reflux. Actually, they have better bolus clearance efficiency following reflux and may even have better control over the number of GER episodes that reach the proximal esophagus. CC of AGER, however, is significantly prolonged in the CF cohort, likely due to hyperacidity of refluxed gastric contents.
Similar content being viewed by others
References
Scott RB, O’Loughlin EV, Gall DG. Gastroesophageal reflux in patients with cystic fibrosis. J Pediatr. 1985;106:223–227.
Vinocur CD, Marmon L, Schidlow DV, et al. Gastroesophageal reflux in the infant with cystic fibrosis. Am J Surg. 1985;149:182–186.
Ledson MJ, Tran J, Wallshaw MJ. Prevalence and mechanisms of gastroesophageal reflux in adult cystic fibrosis patients. J R Soc Med. 1998;91:7–9.
Brodzicki J, Trawinska-Bartnicka M, Korzon M. Frequency, consequences and pharmacological treatment of gastroesophageal reflux in children with cystic fibrosis. Med Sci Monit. 2002;8:CR529–CR537.
Cucchiara S, Santamaria F, Andreotti MR, et al. Mechanisms of gastro-oesophageal reflux in cystic fibrosis. Arch Dis Child. 1991;66:617–622.
Blondeau K, Pauwels A, DuPont LJ, et al. Characteristics of gastroesophageal reflux and potential risk of gastric content aspiration in children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2010;50:161–166.
Helm JF, Dodds WJ, Riedel DR, et al. Determinants of esophageal acid clearance in normal subjects. Gastroenterology. 1983;85:607–612.
Boyd DD, Carney CN, Powell DW. Neuro-hormonal control of esophageal epithelial electrolyte transport. Am J Physiol. 1980;239:G5–G11.
Hamilton BH, Orlando RC. In vivo alkaline secretion by mammalian esophagus. Gastroenterology. 1989;97:640–648.
Myers RL, Orlando RC. In vivo bicarbonate secretion by human esophagus. Gastroenterology. 1992;103:1174–1178.
Woodley FW, Fernandez S, Mousa H. Diurnal variation in the chemical clearance of acid gastroesophageal reflux in infants. Clin Gastroenterol Hepatol. 2007;5:37–43.
Woodley FW, Hayes J, Mousa H. Acid gastroesophageal reflux in symptomatic infants is primarily a function of classic 2-phase and pH-only acid reflux event types. J Pediatr Gastroenterol Nutr. 2009;48:550–558.
Rudolph CD, Mazur LJ, Liptak GS, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatric Gastroenterol Nutr. 2001;32:S1–S31.
Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024–1031.
Helm JF, Dodds WJ, Pelc LR, et al. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med. 1984;310:284–288.
Woodley FW, Machado RS, Benner J, et al. Normal values for chemical clearance of acid gastroesophageal reflux in infants and children. Gastroenterol. 2013;144:399–400.
Kim BJ, Choi SC, Kim JJ, et al. Pathological bolus exposure plays a significant role in eliciting non-cardiac chest pain. J Gastroenterol Hepatol. 2010;25:1855–1860.
Meyers RL, Orlando RC. In vivo bicarbonate secretion by human esophagus. Gastroenterology. 1992;103:1174–1178.
Boyd DD, Carney CN, Powell DW. Neurohumoral control of esophageal epithelial electrolyte transport. Am J Physiol. 1980;239:G5–G11.
Hamilton BH, Orlando RC. In vivo alkaline secretion by mammalian esophagus. Gastroenterology. 1989;97:640–648.
Abdulnour-Nakhoul S, Nakhoul NL, Orlando RC. Lumen-to-surface pH gradients in opossum and rabbit esophagi: role of submucosal glands. Am J Physiol Gastrointest Liver Physiol. 2000;278:G113–G120.
Abdulnour-Nakhoul S, Nakhoul HN, Medhat K, et al. Ion transport mechanisms linked to bicarbonate secretion in the esophageal submucosal glands. Am J Physiol Regul Integr Comp Physiol. 2011;301:R83–R96.
Trezise AEO, Buchwald M. In vivo cell-specific expression of cystic fibrosis transmembrane conductance regulator. Nature. 1991;353:434–437.
Van Slyke DD. Studies of acidosis –XVII. Determination of the bicarbonate concentration of the blood and plasma. J Biol Chem. 1922;52:495–499.
Chauncey HH, Levine DM, Kass G, et al. Composition of human saliva; parotid gland secretory gland rate and electrolyte concentration in children with cystic fibrosis. Arch Oral Biol. 1962;7:707–713.
Kaufman E, Lamster IB. The diagnostic applications of saliva—a review. Crit Rev Oral Biol Med. 2002;13:197–212.
Bradley PJ, Guntinas-Lichius O. Salivary gland disorders and diseases: diagnosis and management. New York: NY. Georg Thieme Verlag; 2001.
Davies H, Bagg J, Goodchild M, et al. Defective regulation of electrolyte and protein secretion in submandibular saliva of cystic fibrosis. Acta Paediatr Scand. 1991;80:1094–1095.
Aps JK, Delanghe J, Martens LC. Salivary electrolyte concentrations are associated with cystic fibrosis transmembrane regulator genotypes. Clin Chem Lab Med. 2002;40:345–350.
Goncalves AC, de Lima Marson FA, de Holanda Mendona RM et al. Saliva as a potential tool for cystic fibrosis diagnosis. Diagn Pathol. 2013;8:46.
Hardt M, Witkowska HE, Webb S, et al. Assessing the effects of diurnal variation on the composition of human parotid saliva: quantitative analysis of native peptides using iTRAQ reagents. Anal Chem. 2005;77:4947–4954.
Blomfield J, Allars HM, Rush AR, et al. Parotid serous hypersecretion in cystic fibrosis. Aust Paediatr J. 1974;10:75–81.
Blomfield J, Van Lennep EW, Shorey CD, et al. Ultrastructure of the in vitro formation of hydroxyapatite in submandibular saliva of children with cystic fibrosis. Arch Oral Biol. 1974;19:1153–1160.
Lidums I, Holloway RH. Motility abnormalities in the columnar-lined esophagus. Gastroenterol Clin. 1997;26:519–531.
Ko SB, Zeng W, Dorwart MR, et al. Gating for CFTR by STATS domain of SLC26 transporters. Nat Cell Biol. 2004;6:343–350.
Stewart AK, Yamamoto A, Nakakuki M, et al. Functional coupling of apical Cl−/HCO3 − exchange with CFTR in stimulated secretion by guinea pig interlobular pancreatic duct. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1307.
Rozmanic V, Tjesic-Drinkovic D, Banac Srdan, et al. Gastroesophageal reflux and gastric hyperacidity in cystic fibrosis patients. Pedijatrija Danas 2010;6(1):45–52.
Cox KL, Isenberg JN, Ament MEI. Gastric acid hypersecretion in cystic fibrosis. J Pediatr Gastroenterol Nutr. 1981;1:559–565.
Sawaf NW, Orzel JA, Weiland FL. Gastroesophageal reflux demonstrated by hepatobiliary imaging in scleroderma. J Nucl Med. 1987;28:387–389.
Simren M, Silny J, Holloway R, et al. Relevance of ineffective esophageal motility during oesophageal acid clearance. Gut. 2003;52:784–790.
Pauley KM, Lee BH, Gauna AE, et al. Mechanisms of salivary gland secretory dysfunction in Sjorgren’s syndrome. In: Harrison A ed. Insights and perspectives in rheumatology. 2012. ISBN:978-953-3007-846-5.
de Veer AJ, Bos JT, Niezen-de Boer RC, et al. Symptoms of gastroesophageal reflux disease in severely mentally retarded people: a systematic review. BMC Gastroenterol. 2008;8:23–35.
Ruigómez A, Wallander MA, Lundborg P, et al. Gastroesophageal reflux disease in children and adolescents in primary care. Scand J Gastroenterol. 2010;45:139–146.
Kellogg DL, Hodges GJ, Orozco CR, et al. Cholinergic mechanisms of cutaneous active vasodilation during heat stress in cystic fibrosis. J Appl Physiol. 2007;103:963–968.
Zheng W, Kuhlicke J, Jackel K, et al. Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium. FASEB J. 2009;23:204–213.
Ribeiro CMP, Paradiso AM, Carew MA, et al. Cystic fibrosis airway epithelial Ca2+ I signaling. J Biol Chem. 2005;280:10202–10209.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Woodley, F.W., Machado, R.S., Hayes, D. et al. Children with Cystic Fibrosis Have Prolonged Chemical Clearance of Acid Reflux Compared to Symptomatic Children Without Cystic Fibrosis. Dig Dis Sci 59, 623–630 (2014). https://doi.org/10.1007/s10620-013-2950-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-013-2950-0